Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Castration-resistant Prostate Cancer × VT-464 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Neoplasm Metastasis 1 Castration-resistant Prostate Cancer 1

Interventions

radium Ra 223 dichloride 1 enzalutamide 1 disitamab vedotin 1 dactolisib 1 VT-464 1 NVP-BKM120 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02361086 2019-02-01

A Study to Evaluate Once-Daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer

Innocrin Pharmaceutical

Phase 1/2 Completed

Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡